Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 12:51 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2833–2856 of 7,489 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Standard Control Clear all

Conditions: Patient Preference
Interventions: Dexamethasone, Standard of care surgery; Drug · Other
Lead sponsor: Ophthalmic Consultants of Long Island; Other
Eligibility: 22 Years to 100 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Garden City, New York

Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: dupilumab, Placebo; Drug
Lead sponsor: Regeneron Pharmaceuticals; Industry
Eligibility: 40 Years and older
Enrollment: 754 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Mullica Hill, New Jersey

Conditions: Diabetes Mellitus, Type 2, Diabetes Mellitus, Adult-Onset, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Noninsulin Dependent, Diabetes Mellitus, Type II
Interventions: Technology Intensified; Behavioral
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 21 Years to 100 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2026
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Endometrial Cancer
Interventions: AEZS-108 / zoptarelin doxorubicin, doxorubicin; Drug
Lead sponsor: AEterna Zentaris; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 511 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 28
States / cities: Phoenix, Arizona • Los Angeles, California • Orange, California + 24 more

Conditions: Stroke Acute
Interventions: Endovascular Therapy (Mechanical Thrombectomy), Standard Medical Management; Other
Lead sponsor: Santiago Ortega Gutierrez; Other
Eligibility: 18 Years to 80 Years
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Stress Disorders, Post-Traumatic, Drinking Heavy
Interventions: Trauma Expressive Writing, Stigma Expressive Writing, Control; Behavioral
Lead sponsor: Syracuse University; Other
Eligibility: 18 Years and older
Enrollment: 131 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Syracuse, New York

Conditions: Osteoarthritis
Interventions: Standard of care for osteoarthritis treatment, Conjoint Analysis for Osteoarthritis; Behavioral
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 65 Years to 95 Years
Enrollment: 182 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Alopecia Areata, Scarring Alopecia
Interventions: tSVF by lipoaspiration, PRP Concentration, Emulsification tSVF, cSVF isolation and concentration, cSVF in Normal Saline IV; Procedure
Lead sponsor: Regeneris Medical; Other
Eligibility: 18 Years to 75 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2025
U.S. locations: 3
States / cities: Irvine, California • North Attleboro, Massachusetts • Stevensville, Montana

Conditions: Purpura, Thrombocytopaenic, Idiopathic
Interventions: eltrombopag, Placebo; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years and older
Enrollment: 197 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 26
States / cities: Duarte, California • Los Angeles, California • San Francisco, California + 20 more

Conditions: Glioblastoma Multiforme
Interventions: ICT-107, Placebo; Biological
Lead sponsor: Precision Life Sciences Group; Industry
Eligibility: 18 Years and older
Enrollment: 234 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 58
States / cities: Birmingham, Alabama • Phoenix, Arizona • Duarte, California + 43 more

Conditions: Tobacco Use
Interventions: Click City®: Tobacco, Usual Tobacco Curriculum; Other
Lead sponsor: Oregon Research Behavioral Intervention Strategies, Inc.; Industry
Eligibility: 9 Years to 12 Years
Enrollment: 2,673 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Springfield, Oregon

Conditions: Aging, Fall Injury Prevention, At Fall Risk
Interventions: Neck Strengthening Exercises; Other
Lead sponsor: Ohio University; Other
Eligibility: 65 Years and older
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Athens, Ohio

Conditions: Heart Failure, Diabetes Mellitus
Interventions: Libre 2 rt-CGM, POC BG + Blinded CGM; Device · Diagnostic Test
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: ARDS (Moderate or Severe), AHRF, Mechanically Ventilated ICU Patients
Interventions: Phrenic Nerve Stimulation; Device
Lead sponsor: Lungpacer Medical Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 6
States / cities: La Jolla, California • Shreveport, Louisiana • Winston-Salem, North Carolina + 3 more

Conditions: Port-Wine Stain
Interventions: 532 nm laser treatment; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 75 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cancer of Head and Neck, Narcotic Use
Interventions: Gabapentin, Placebo - Concentrate; Drug
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Constipation
Interventions: Laxative Treatment, Standard of Care, Assessment Questionnaires; Other
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 601 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Chronic Low Back Pain (CLBP)
Interventions: Standard Physical Therapy, Lumbar Extensor Strengthening plus Standard Physical Therapy; Other
Lead sponsor: Brooke Army Medical Center; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Fort Sam Houston, Texas

Conditions: Asthma
Interventions: QAW039 150 mg, QAW039 450 mg, Placebo; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 12 Years and older
Enrollment: 2,538 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 46
States / cities: Birmingham, Alabama • Encinitas, California • Newport Beach, California + 41 more

Conditions: Lumbar Puncture
Interventions: Ultrasound-Assisted Lumbar Puncture, Standard Palpation-Guided Lumbar Puncture; Procedure · Other
Lead sponsor: Cooper Norcross Health; Other
Eligibility: 18 Years and older
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 2
States / cities: Camden, New Jersey • Pittsburgh, Pennsylvania

Conditions: Poverty, Tax Policy
Interventions: Paycheck Plus; Other
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 1,350 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Meditation, Spine Surgery, Pain, Postoperative
Interventions: Mindfulness meditation; Behavioral
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years to 80 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Eosinophilic Esophagitis
Interventions: Fluticasone Propionate, Budesonide; Drug
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 4 Years to 18 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Patient Satisfaction, Patient Compliance, Guideline Adherence
Interventions: Chemo Buddy; Behavioral
Lead sponsor: Boston Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Boston, Massachusetts

Search by objective public record fields.

A Trial Evaluating Patient Preference of Dropless vs Drops Post Cataract Surgery

This After Market Study is Seeing if Dupilumab Plus Usual Standard of Care (SOC) is Better Than Usual Care Alone for Adult Participants After a Severe Chronic Obstructive Pulmonary Disease (COPD) Flare-Up Requiring Hospitalization

Technology Intensified Diabetes Education Study in African Americans

Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer

EnDOvascular Therapy for Late WiNdow IschEmic Stroke Patients Selected bY AutoMatic Plain ComputErized Tomography

Project QueST 2023: Queer Survivors of Trauma

Conjoint Analysis of Treatment Preferences for Osteoarthritis

Biocellular-Cellular Regenerative Treatment Scaring Alopecia and Alopecia Areata

RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag

Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma

Expanding the Click City Tobacco Prevention Program to Include E-cigarettes and Other Novel Tobacco Products

Older Adult Traditional Balance Training vs Traditional Balance Training Plus Neck Strengthening

CGM Use in Heart Failure

STimulation to Activate RespIration

Tolerability of 532 nm Laser Treatment of Port Wine Stains

Perioperative Analgesia Using Gabapentin in Head and Neck Cancer Surgery

Managing Medication-induced Constipation in Cancer: A Clinical Trial

Lumbar Extension Strengthening in Addition to Manual Therapy and Exercise for Chronic Low Back Pain

Study of Safety of QAW039 in Patients With Asthma Inadequately Controlled on Standard-of-care Asthma Treatment

Ultrasound-assisted vs Palpation-guided Lumbar Punctures

Effect of EITC on Biological Markers of Aging, Health and Mortality

Mindfulness Meditation for Spine Surgery Pain

Cycling of Topical Steroids for Treatment of EoE (Eosinopilic Esophagitis)

Study Buddy (an ECA Oncology Trial Advisor) for Cancer Trials